Todd Schlesinger

1.1k total citations
59 papers, 505 citations indexed

About

Todd Schlesinger is a scholar working on Dermatology, Epidemiology and Oncology. According to data from OpenAlex, Todd Schlesinger has authored 59 papers receiving a total of 505 indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Dermatology, 27 papers in Epidemiology and 13 papers in Oncology. Recurrent topics in Todd Schlesinger's work include Nonmelanoma Skin Cancer Studies (23 papers), Dermatologic Treatments and Research (13 papers) and Cutaneous Melanoma Detection and Management (13 papers). Todd Schlesinger is often cited by papers focused on Nonmelanoma Skin Cancer Studies (23 papers), Dermatologic Treatments and Research (13 papers) and Cutaneous Melanoma Detection and Management (13 papers). Todd Schlesinger collaborates with scholars based in United States, Spain and Canada. Todd Schlesinger's co-authors include Daniel B. Eisen, Robert P. Dellavalle, Peggy A. Wu, Lindsy Frazer-Green, Wilma F. Bergfeld, Edward Lain, David L. Cutler, Maryam M. Asgari, Gary Goldenberg and Charles Camisa and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Journal of the American Academy of Dermatology.

In The Last Decade

Todd Schlesinger

49 papers receiving 485 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Todd Schlesinger United States 13 329 259 163 50 47 59 505
D. Morgado‐Carrasco Spain 14 353 1.1× 105 0.4× 105 0.6× 77 1.5× 43 0.9× 139 625
Georg Popp Germany 10 309 0.9× 162 0.6× 124 0.8× 76 1.5× 70 1.5× 11 470
Maria Mariano Italy 14 276 0.8× 66 0.3× 131 0.8× 57 1.1× 90 1.9× 42 611
W Grabski United States 14 306 0.9× 234 0.9× 121 0.7× 36 0.7× 86 1.8× 40 603
Nishit Patel United States 10 161 0.5× 114 0.4× 139 0.9× 57 1.1× 54 1.1× 31 394
Eleanor Russell‐Goldman United States 11 155 0.5× 84 0.3× 149 0.9× 37 0.7× 92 2.0× 37 499
Rafael Salido‐Vallejo Spain 13 374 1.1× 131 0.5× 74 0.5× 93 1.9× 64 1.4× 43 572
Mario Puviani Italy 11 153 0.5× 111 0.4× 54 0.3× 42 0.8× 58 1.2× 39 399
Paul H. Bowman United States 10 225 0.7× 106 0.4× 46 0.3× 35 0.7× 52 1.1× 16 352
Turna İlknur Türkiye 12 250 0.8× 116 0.4× 53 0.3× 42 0.8× 26 0.6× 37 387

Countries citing papers authored by Todd Schlesinger

Since Specialization
Citations

This map shows the geographic impact of Todd Schlesinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Todd Schlesinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Todd Schlesinger more than expected).

Fields of papers citing papers by Todd Schlesinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Todd Schlesinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Todd Schlesinger. The network helps show where Todd Schlesinger may publish in the future.

Co-authorship network of co-authors of Todd Schlesinger

This figure shows the co-authorship network connecting the top 25 collaborators of Todd Schlesinger. A scholar is included among the top collaborators of Todd Schlesinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Todd Schlesinger. Todd Schlesinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bunick, Christopher G., Hossein Akbarialiabad, Todd Schlesinger, et al.. (2025). Advances in Cell-Mediated Drug Delivery for Dermatologic Diseases: Mechanisms and Current Applications. Pharmaceutics. 17(11). 1438–1438.
2.
Schlesinger, Todd, et al.. (2025). Exosomes: Historical Evolution and Emerging Roles in Dermatology. Journal of Cosmetic Dermatology. 24(1). e16769–e16769. 5 indexed citations
3.
Patel, Vishal, Sarah T. Arron, Brian Berman, et al.. (2025). Expert consensus-based recommendations on the use of photodynamic therapy in actinic keratosis patients. JAAD International. 20. 62–73. 1 indexed citations
4.
Schlesinger, Todd, et al.. (2024). Update on Low-Molecular Weight Hyaluronic Acid in Dermatology: A Scoping Review. SHILAP Revista de lepidopterología. 134–146. 6 indexed citations
6.
Gold, Michael H., Brian S. Biesman, Joel L. Cohen, et al.. (2024). Real‐World Clinical Experience With an Allograft Adipose Matrix for Replacing Volume Loss in Face, Hands, and Body. Journal of Cosmetic Dermatology. 23(S4). 1–9. 1 indexed citations
7.
Simpson, Eric L., Melinda Gooderham, Leon Kircik, et al.. (2024). 53652 Efficacy and safety of eblasakimab in adults with severe atopic dermatitis: a posthoc analysis of the Phase 2b TREK-AD trial. Journal of the American Academy of Dermatology. 91(3). AB194–AB194. 1 indexed citations
8.
Schlesinger, Todd, et al.. (2024). Basic Science and Principles of Stem Cells, Platelet‐Rich Plasma, and Exosomes. 5(4). 4 indexed citations
9.
Rosso, J.Q. Del, Hilary Baldwin, Neal Bhatia, et al.. (2024). A Review of the Diagnostic and Therapeutic Gaps in Rosacea Management: Consensus Opinion. Dermatology and Therapy. 14(2). 271–284. 2 indexed citations
10.
Schlesinger, Todd, Leon Kircik, J.Q. Del Rosso, et al.. (2023). Clinician- and Patient-Reported Outcomes with Tirbanibulin 1% Treatment for Actinic Keratosis in Routine Clinical Practice Across the U.S. (PROAK Study). SKIN The Journal of Cutaneous Medicine. 7(3). 771–787. 4 indexed citations
11.
Gold, Michael H., Anneke Andriessen, Cheryl Burgess, et al.. (2023). Promoting a Healthy Skin Barrier Using Skin Care in People With Mature Skin Xerosis. Journal of Drugs in Dermatology. 23(1). 1253–1259. 3 indexed citations
12.
Schlesinger, Todd, et al.. (2023). Belotero: What we know now. 4(2). 96–99. 1 indexed citations
13.
Pearlman, Ross, et al.. (2023). Introduction to soft tissue fillers. 4(2). 79–81. 3 indexed citations
14.
Schlesinger, Todd, et al.. (2023). Restylane: What we know. 4(2). 86–89. 1 indexed citations
16.
Schlesinger, Todd, et al.. (2023). Permanent fillers—What is their role. 4(3). 121–126.
18.
Armstrong, April W., Brian Berman, J.Q. Del Rosso, et al.. (2023). The Importance of Medication Adherence in the Treatment of Actinic Keratosis: An Expert Consensus Panel. SKIN The Journal of Cutaneous Medicine. 7(3). 752–763. 2 indexed citations
19.
Schlesinger, Todd, Eggert Stockfleth, Ayman Grada, & Brian Berman. (2022). Tirbanibulin for Actinic Keratosis: Insights into the Mechanism of Action. Clinical Cosmetic and Investigational Dermatology. Volume 15. 2495–2506. 22 indexed citations
20.
Rabinowits, Guilherme, Michael R. Migden, Todd Schlesinger, et al.. (2021). Evidence-Based Consensus Recommendations for the Evolving Treatment of Patients with High-Risk and Advanced Cutaneous Squamous Cell Carcinoma. SHILAP Revista de lepidopterología. 1(4). 100045–100045. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026